Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab

Fig. 3

Mean change in treatment outcomes over time (stratified by Hb level at baseline)—MONARCH. CDAI, Clinical Disease Activity Index; CRP, C-reactive protein; DAS28-CRP, Disease Activity Score-28 for Rheumatoid Arthritis with CRP; Hb, hemoglobin; PtGA, Patient Global Assessment; MDGA, Physician Global Assessment; q2w, every 2 weeks; VAS, visual analog scale

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us